AI Assistant
Blog
Pricing
Log In
Sign Up
DAPA-HF trial: dapagliflozin evolves from a glucose-lowering agent to a therapy for heart failure
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.